- Home
- SIMO vs VKTX Comparison
SIMO vs VKTX Comparison
Compare SIMO & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SIMO | VKTX |
|---|---|---|
| Founded | 1995 | 2012 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.7B |
| IPO Year | 2005 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SIMO | VKTX |
|---|---|---|
| Price | $135.91 | $35.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 9 |
| Target Price | ★ $114.38 | $94.44 |
| AVG Volume (30 Days) | 527.0K | ★ 2.2M |
| Earning Date | 04-28-2026 | 04-22-2026 |
| Dividend Yield | ★ 1.44% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $42.27 | N/A |
| Revenue Next Year | $12.78 | N/A |
| P/E Ratio | $36.09 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $37.87 | $22.96 |
| 52 Week High | $146.85 | $43.15 |
Technical Indicators
Market Signals| Indicator | SIMO | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 63.72 | 57.06 |
| Support Level | $126.80 | $33.65 |
| Resistance Level | $145.77 | $36.23 |
| Average True Range (ATR) | 6.00 | 1.81 |
| MACD | 2.62 | 0.20 |
| Stochastic Oscillator | 89.54 | 81.13 |
Price Performance
Historical ComparisonAbout SIMO Silicon Motion Technology Corporation
Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.